Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer
Abdul Rafeh Naqash, Justin D. McCallen, Emma Mi, Sanna Iivanainen, Mona A. Marie, Daria Gramenitskaya, James Clark, Jussi Pekka Koivunen, Shravanti Macherla, Sweta Jonnalagadda, Shanker Polsani, Rahim Ali Jiwani, Maida Hafiz, Mahvish Muzaffar, Leonardo Brunetti, Chipman R.G. Stroud, Paul R. Walker, Kun Wang, Youngmin Chung, Eytan RuppinSe Hoon Lee, Li V. Yang, David J. Pinato, Joo Sang Lee, Alessio Cortellini*
Research output: Contribution to journal › Article › peer-review
7Scopus
citations
Fingerprint
Dive into the research topics of 'Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer'. Together they form a unique fingerprint.